Netsmart accelerates AI healthcare innovations with the acquisition of Remarkable Health
Key Insights and Signals – Hospital & Healthcare
Centre setup and expansion Genesis Health breaks ground on USD 12 Mn expansion Phase 1 is anticipated to be completed by Oct. 1, 2022, and will cost around USD 10 Mn, including the expansion of a 28,000 sq. ft. area for the site. Phase 2 will immediately follow, including the movement of the site’s pharmacy, the addition of a space for ill patients, and expansion of the health care center as a whole to accommodate more patients. Read More>> Deals and Deals Renewal Qumata inks a deal with AIA Group to accelerate innovative digital underwriting The agreement will enable AIA to incorporate Qumata’s ML/AI underwriting solution in its markets across the region. Qumata is transforming the traditionally long and sometimes cumbersome process of underwriting, usually conducted through long questionnaires and medical exams for life and health insurers. Read More>>Partnerships Sonic Healthcare, Harrison.ai complete joint venture The JV combines Harrison.ai’s expertise and comprehensive AI methodologies with Sonic’s clinical experience and distribution capability to create powerful new AI applications to support clinicians in diagnosing patients more effectively and efficiently in pathology. Read More>> Omron partners with Doctor Anywhere to provide telehealth services Through the partnership, Omron will integrate its health monitoring devices with DAs digital platform to enable easy sharing of health data such as heart rates and blood pressure between doctors and patients. The initiative is intended to reduce preventable heart attacks and strokes in the region, where hypertension causes around 1.5 million deaths per year. Read More>> CVS Health’s new alliance with Microsoft to boost digital transformation The Partnership will develop advanced solutions to help consumers boost their health and offer CVS Health employees tools to serve customers better. The alliance will further advance digital transformation and empower employees to deliver quality care that is more customized and affordable. Read More>>Mergers and Acquisitions Netsmart accelerates AI healthcare innovations with the acquisition of Remarkable Health Together, the organizations will accelerate AI innovations and expand the Netsmart CareFabric® platform capabilities with enhanced solutions that improve human services and post-acute care clinical staff productivity and efficiency. Remarkable Health’s CT|One® electronic health record and Bells, the industry’s first virtual clinical documentation solution to join Netsmart. Read More>> Ramsay Healthcare to acquire UK mental health services provider for USD 1.4 Bn With the acquisition, Ramsay will enter the UK mental health market as a leading player with scale and growth opportunities in a sector that is estimated to be worth USD 15 Bn. The acquisition will be funded through the listed healthcare company’s existing debt facilities and is expected to deliver single-digit earnings per share accretion in FY23. Read More>> Aviva officially exits the Italian market Aviva has now fully exited the Italian market following a USD 543 Mn sale of various life insurance businesses to CNP Assurances. The UK insurer had previously offloaded its general insurance business to Allianz for USD 330 Mn in a deal finalized last month. Read More>>Executive Movement Castlight Health welcomes Ethan Prater as Chief Product and Analytics Officer Prater brings decades of digital health and product management experience to further strengthen and elevate Castlight’s industry-leading digital plus high-touch navigation solutions. Prater will play a key role in leveraging Castlight’s wealth of data to drive broader product innovation across the ecosystem. Read More>> Lumeris hires Health System Exec as Chief of Marketing and Communications Lumeris announced the appointment of health system marketing veteran Valerie Simon as SVP and Chief of Marketing and Communications. Valerie brings more than 20 years of success driving revenue growth, brand awareness, and organizational reputation. Read More>>
Key Insights and Signals in Pharmaceutical
Partnerships Eli Lilly partners with Regor in a USD 1.5 Bn deal to focus on Obesity and Diabetes The multi-year collaborative partnership will develop new therapies for metabolic disorders. The partnership allows both companies to benefit from existing compounds and technologies to create new assets. Under the terms of the agreement, Lilly will take the lead in accessing Regor’s intellectual property to begin researching and developing new assets. Read More>> Ksana Health announced selection by Novo Nordisk’s Global Prevention Accelerator Organizations were selected based on a set of criteria, including the ability to make a global impact and provide scalable digital solutions that can be adapted for local populations. Ksana Health will pilot its remote measurement platform, Vira, for health systems and care providers as part of the Prevention Accelerator. Read More>> Health2Sync, Sanofi’s extended partnership to develop a new insulin management solution Health2Sync will develop an insulin management solution with titration algorithms, which will be “the first of its kind in Asia.” The companies note how “timely” titration alerts are promising for effective communication between healthcare providers and patients and helpful for patients wanting to achieve their desirable HbA1c faster. Read More>> Ionis collaborates with AstraZeneca for Eplontersen The Partnership will develop and commercialize Eplontersen in the United States. Eplontersen, formerly known as IONIS-TTR-LRx, is Ionis’ investigational antisense medicine for treating transthyretin amyloidosis (ATTR), a progressive and fatal disease. Read More>>Deals Advanz Pharma signs a contract with Avaali to transform its P2P Processes As part of this agreement, Avaali will work with Advanz Pharma to automate and streamline its Procure to Pay processes. With this engagement, Avaali will revamp and optimize Advanz Pharma’s Invoice processing (Scan to payment) and Finance workflows with SAP Invoice Management Solution by OpenText for SAP S/4 HANA. Read More>> Roche signs ML Neuroscience deal with Recursion The agreement allows for as many as 40 experimental programs to emerge from the Recursion technology, part of a broader Roche effort to invest in platforms that can underpin an array of medicines. The Swiss drugs giant will pay Recursion of USD 150 Mn in an upfront payment, plus royalties and development, commercialization, and revenue milestones that could exceed USD 300 Mn for each project. Read More>>Mergers and Acquisition CSL in talks to buy Swiss-based Vifor Pharma Group for USD 10 Bn Biotech giant CSL is in talks to acquire Vifor Pharma Group that would be its largest acquisition since it was listed on the Australian Securities Exchange nearly three decades ago. Bank of America advises the USD 139 Bn giant on how it can most effectively fund buying Vifor, which could include an equity raising of about USD 4 Bn. Read More>>
Key Insights and Signals in Medical Devices
Centre set up and Expansion Fujifilm plans a USD 533 Mn UK biopharma facility Fujifilm Diosynth Biotechnologies has confirmed the investment at its UK facility in Billingham, Teesside. With upgrades coming to its capabilities in biologics, viral gene therapy, mRNA production, and more, the investment is set to more than double the site’s current development and manufacturing footprint. Read More>>Deals Clarity and Cardinal Health ink a deal for Targeted Copper Theranostics Cardinal Health will provide cGMP product manufacturing of ready-to-use TCT for Clarity’s U.S.-based clinical trials from its Center for Theranostic Advancement in Indianapolis, Indiana. Cardinal Health has an intricate understanding of the supply chain requirements for copper-based products and the capability to mass-produce these products. Read More>>Partnerships GE Healthcare inks software deployment agreements with three new partners The company plans to deploy AI solutions to simplify oncology patient workflows, help clinicians better understand increasingly complex clinical patient data, and compare data of individual patients. It will develop these solutions using diverse sources, including EHRs, RIS, scanners, and other medical devices. Read More>> Rockwell Automation, Cytiva collaborate to accelerate automation in the biopharmaceutical industry Cytiva joined the Rockwell Automation PartnerNetwork Program as an OEM Partner to help drive a best-in-class distributed control system offering. The companies are building an Automation and Digital Transformation Center located in Shanghai to co-host demonstrations, trainings, and more. Read More>>Mergers and Acquisitions Thermo Fisher Scientific completes acquisition of PPD, Inc. for USD 17.4 Bn With the addition of PPD, Thermo Fisher will offer a comprehensive suite of world-class services across the clinical development spectrum − from scientific discovery to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product. Read More>> Integer Holdings buys Oscor to expand its global footprint The acquisition expands Integer’s cardiovascular and neurostimulation product portfolio through broadened product offering and the addition of low-cost manufacturing capacity. The acquired company designs, manufactures, and markets an all-inclusive portfolio of highly specialized medical devices, venous access systems, diagnostic catheters, and implantable devices. Read More>>Executive Movement Baxter & Woodman appoints Chief Innovation Officer Matthew D. Washkowiak will drive innovation strategies within the company and promote the value and influence that innovation brings. As a member of the firm’s Strategic Planning Group, Washkowiak will champion change management for innovation enhancements firm-wide. Read More>>
Did you find the newsletter helpful? *|SURVEY: Yes|* *|SURVEY: No|*
Latest Industry Insights from Draup Braindesk
Clinical Research Organizations have increased their spending on Artificial intelligence, Cloud, and Quantum computing to revolutionize clinical trial processes.
Mayo Clinic is making significant investments in digital infrastructure and Artificial intelligence to transform in-person and virtual care platforms to develop intelligent hospitals.
Eli Lilly partnered with Tencent to empower medical services with Cloud technology, extensive data analysis, and Artificial intelligence and build a patient-centric, innovative medical ecological system.
Blackford collaborated with Bayer to develop a new Cloud-based medical imaging platform for the life science company and provide cloud access to digital and AI applications.
RetinAI collaborated with Novartis to leverage RetinAI’s IT solutions and AI tools to support multiple projects in ophthalmology and digital health.
Clinical Research companies intend to launch Data platforms to deliver digital solutions for complex healthcare problems.
Cleveland Clinic collaborated with American Well to develop a digital health technology platform to deliver digital solutions for complex healthcare problems.
Syneos Health partnered with Science 37 for providing a seamless technology platform to streamline workflow orchestration, real-world evidence generation, and data harmonization.
Harbour BioMed developed antibody technology platform “Harbour Mice” to generate human therapeutic antibodies. The platform has the potential for generating both conventional & next-generation biologics.
Key Funding Alert
Medtech startup Harrison.ai bags USD 92.3 Mn in a Series B led by Horizons Ventures
The funding will be used to hire more AI data scientists and engineers and form clinical partnerships worldwide to expand into new healthcare areas. Harrison.ai said its AI-based technology could help improve the diagnosis process in places with a healthcare shortage. Read More>>
Company – Navina Total Funding– USD 22 Mn About: Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care. Its technology creates a new era of simplicity by restructuring disorganized data into an intelligible patient portrait, intuitively organized for sophisticated and empathetic patient care. Read More>>
Latest Reports Published in Draup
Cleveland clinic Account Intelligence Report: Cleveland Clinic focuses on AI-based Drug Discovery by utilizing the Hybrid cloud, Artificial intelligence (AI), and Quantum computing technologies to empower Big data medical research in ethical, privacy-preserving discoveries for patient care. Read More>>
West Pharmaceutical Services Account Intelligence Report: West Pharmaceutical Services focus on developing innovative, high-quality injectable solutions and services. It helps ensure the safe, effective containment and delivery of life-saving & life-enhancing medicines for patients. Read More>>
Here’s what’s new on our Sales Intelligence Platform Discover New Accounts Based on Hiring Strategy
Introducing Hiring filter in Universe to help you discover accounts based on the hiring strategy
Introducing Procurement Locations Analysis in the Locations section in the Account Profile
You can set alerts in the Signals section to keep a tap on special events
Get to see your accounts partnership events as they happen in your home page feed
Introducing ‘Announcements’ information in the Financials section
Draup made your Braindesk search intelligent by suggesting you relevant account profiles and subscription limitation information
Introducing Service Provider Partner Locations filter in the Outsourcing information table in the Outsourcing section
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!